Health Care • Hospital/Nursing Management
$212.16 ▲ +0.37
(+0.18%)
MKT CAP: $3.32B • VOL: 145.7K
52W L $118 52W H $248
NHC // SEC EDGAR XBRL STANDARDIZED FINANCIAL STATEMENTS (FA <GO>)
| LINE ITEM (USD / %) | FY 2025
FILED 2025-12-31 | FY 2024
FILED 2024-12-31 | FY 2023
FILED 2023-12-31 |
|---|---|---|---|
| Revenue (Total Sales) | $1.52B | $1.31B | $1.14B |
| YoY Revenue Growth % | +16.1% | +14.5% | — |
| Gross Profit | — | — | — |
| Gross Margin % | — | — | — |
| Research & Development (R&D) | — | — | — |
| Operating Income (EBIT) | $128.4M | $89.9M | $57.5M |
| Operating Margin % | 8.5% | 6.9% | 5.0% |
| Net Income (GAAP) | $120.0M | $101.9M | $66.8M |
| EBITDA (Normalized) | $157.5M | $112.0M | — |
| Diluted EPS ($/sh) | — | — | — |
| Operating Cash Flow (OCF) | $185.1M | $107.3M | $111.2M |
| Capital Expenditures (CapEx) | $36.4M | $27.6M | — |
| Free Cash Flow (FCF) | $148.6M | $79.7M | $111.2M |
| FCF Margin % | 9.8% | 6.1% | 9.7% |
| Return on Invested Capital (ROIC %) | 10.1% | 6.9% | — |
| Cash & Short-Term Equivalents | $92.8M | $76.1M | — |
| Total Debt (Short + Long Term) | $32.5M | $129.5M | — |
| Total Stockholders' Equity | $1.07B | $980.2M | — |
NO QUARTERLY 10-Q XBRL STATEMENTS AVAILABLE IN CURRENT CACHE FOR NHC.